JP2016519285A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519285A5
JP2016519285A5 JP2016502266A JP2016502266A JP2016519285A5 JP 2016519285 A5 JP2016519285 A5 JP 2016519285A5 JP 2016502266 A JP2016502266 A JP 2016502266A JP 2016502266 A JP2016502266 A JP 2016502266A JP 2016519285 A5 JP2016519285 A5 JP 2016519285A5
Authority
JP
Japan
Prior art keywords
pancreatic cancer
level
cancer biomarker
subject
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502266A
Other languages
English (en)
Japanese (ja)
Other versions
JP6646571B2 (ja
JP2016519285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/026857 external-priority patent/WO2014160499A2/en
Publication of JP2016519285A publication Critical patent/JP2016519285A/ja
Publication of JP2016519285A5 publication Critical patent/JP2016519285A5/ja
Application granted granted Critical
Publication of JP6646571B2 publication Critical patent/JP6646571B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502266A 2013-03-13 2014-03-13 膵臓がんを検出するための方法および組成物 Expired - Fee Related JP6646571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361780574P 2013-03-13 2013-03-13
US61/780,574 2013-03-13
PCT/US2014/026857 WO2014160499A2 (en) 2013-03-13 2014-03-13 Methods and compositions for detecting pancreatic cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020001856A Division JP7109008B2 (ja) 2013-03-13 2020-01-09 膵臓がんを検出するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2016519285A JP2016519285A (ja) 2016-06-30
JP2016519285A5 true JP2016519285A5 (cg-RX-API-DMAC7.html) 2017-03-30
JP6646571B2 JP6646571B2 (ja) 2020-02-14

Family

ID=50933479

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016502266A Expired - Fee Related JP6646571B2 (ja) 2013-03-13 2014-03-13 膵臓がんを検出するための方法および組成物
JP2020001856A Active JP7109008B2 (ja) 2013-03-13 2020-01-09 膵臓がんを検出するための方法および組成物
JP2022109693A Withdrawn JP2022141755A (ja) 2013-03-13 2022-07-07 膵臓がんを検出するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020001856A Active JP7109008B2 (ja) 2013-03-13 2020-01-09 膵臓がんを検出するための方法および組成物
JP2022109693A Withdrawn JP2022141755A (ja) 2013-03-13 2022-07-07 膵臓がんを検出するための方法および組成物

Country Status (7)

Country Link
US (3) US20160033511A1 (cg-RX-API-DMAC7.html)
EP (1) EP2972375A2 (cg-RX-API-DMAC7.html)
JP (3) JP6646571B2 (cg-RX-API-DMAC7.html)
AU (3) AU2014243704A1 (cg-RX-API-DMAC7.html)
CA (1) CA2902841A1 (cg-RX-API-DMAC7.html)
HK (1) HK1214652A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014160499A2 (cg-RX-API-DMAC7.html)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2347775T3 (da) 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
AU2008231575A1 (en) 2007-03-27 2008-10-02 Immunovia Ab Protein signature/markers for the detection of adenocarcinoma
EP2624873B1 (en) 2010-10-06 2019-12-04 President and Fellows of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
HK1200037A1 (en) 2011-09-12 2015-07-31 克里蒂科斯有限责任公司 Non-invasive methods of detecting target molecules
EP2836512B1 (en) 2012-04-11 2018-10-24 F.Hoffmann-La Roche Ag Improved antibody light chains
LT2838515T (lt) 2012-04-16 2020-03-10 President And Fellows Of Harvard College Mezoporinės silico dioksido kompozicijos, skirtos imuninio atsako moduliavimui
EA201492284A1 (ru) 2012-06-27 2015-11-30 Берг Ллк Применение маркеров в диагностике и лечении рака предстательной железы
LT3290046T (lt) 2013-03-15 2019-03-12 Shire Viropharma Incorporated C1-inh kompozicijos ir sutrikimų, susijusių su c1 esterazės inhibitoriaus nepakankamumu, prevencijos bei gydymo būdai
EP3159695A3 (en) * 2013-06-20 2017-07-05 The Trustees of The University of Pennsylvania Methods for diagnosing pancreatic cancer
BR112016023046A8 (pt) 2014-04-04 2021-05-11 Mayo Found Medical Education & Res kit compreendendo anticorpos e agentes redutores
WO2015168379A2 (en) 2014-04-30 2015-11-05 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
CN106461678A (zh) * 2014-05-26 2017-02-22 奥林巴斯株式会社 胰腺癌判定方法
KR20160045547A (ko) * 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
CN107428821B (zh) 2014-12-08 2022-06-24 博格有限责任公司 包括细丝蛋白a的标志物在诊断和治疗前列腺癌中的用途
US10006915B2 (en) 2014-12-19 2018-06-26 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
WO2016096785A1 (en) 2014-12-19 2016-06-23 F. Hoffmann-La Roche Ag Identification of transglutaminase substrates and uses therefor
HK1247861A1 (zh) 2015-01-30 2018-10-05 President And Fellows Of Harvard College 用於癌症治疗的肿瘤周围和肿瘤内部材料
US20160271120A1 (en) * 2015-03-17 2016-09-22 Oakdene Holdings Llc Pharmaceutical composition for cleansing of the gastrointestinal tract
GB201505654D0 (en) * 2015-04-01 2015-05-13 Nordic Bioscience As Immunoassay for collagen type VI sequence
WO2016164593A1 (en) * 2015-04-07 2016-10-13 President And Fellows Of Harvard College Compositions and methods for modulating hydroxylation of acc2 by phd3
CN107708756A (zh) 2015-04-10 2018-02-16 哈佛学院院长等 免疫细胞捕获装置及其制备和使用方法
ES2939013T3 (es) * 2015-04-20 2023-04-18 Consejo Superior Investigacion Agentes que se unen específicamente al motivo RGD de la cadherina 17 humana, la cadherina 5 humana, la cadherina 6 humana y la cadherina 20 humana
HK1254866A1 (zh) 2015-06-25 2019-07-26 Immatics Biotechnologies Gmbh 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物
GB201511191D0 (en) * 2015-06-25 2015-08-12 Immatics Biotechnologies Gmbh T-cell epitopes for the immunotherapy of myeloma
WO2017036369A1 (en) * 2015-09-03 2017-03-09 The University Of Hong Kong A monoclonal antibody for predicting tamoxifen response in breast cancer patients
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
CN105296613A (zh) * 2015-09-24 2016-02-03 郑州市职业病防治院 一种人TERF1基因rs3863242位点多态性检测技术
WO2017095632A1 (en) * 2015-11-30 2017-06-08 Mayo Foundation For Medical Education And Research Heatr1 as a marker for chemoresistance
CN105785013A (zh) * 2016-04-21 2016-07-20 卢连伟 一种辅助检测胰腺癌的胶体金免疫层析试纸及其制备方法
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
JP7075125B2 (ja) * 2016-05-25 2022-05-25 イマティクス バイオテクノロジーズ ゲーエムベーハー 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ
ES3032115T3 (en) 2016-07-13 2025-07-15 Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
WO2018026884A1 (en) 2016-08-02 2018-02-08 President And Fellows Of Harvard College Biomaterials for modulating immune responses
EP3523647B1 (en) 2016-09-07 2024-06-26 Mayo Foundation for Medical Education and Research Identification and monitoring of cleaved immunoglobulins by molecular mass
CN107655985B (zh) * 2017-08-25 2020-05-26 南京农业大学 一种基于lc-ms-ms技术的体内蛋白质营养的评价方法
EP3681907A4 (en) 2017-09-13 2021-07-07 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
CA3092292A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
WO2020101878A2 (en) * 2018-10-29 2020-05-22 The Johns Hopkins University Rasopathy treatment
WO2020223646A1 (en) * 2019-05-02 2020-11-05 Creatics Llc Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
BR112021026192A2 (pt) * 2019-06-24 2022-06-07 Urteste S A Marcador de diagnóstico para câncer pancreático
EP4045912A1 (en) * 2019-10-18 2022-08-24 Reccan Diagnostics AB Apparatuses and methods for detection of pancreatic cancer
WO2021239692A1 (en) * 2020-05-26 2021-12-02 F. Hoffmann-La Roche Ag Computer implemented method for calibrating a customer mass spectrometry instrument for quantifier-qualifier-ratio check
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
KR102448586B1 (ko) * 2020-10-08 2022-09-27 가톨릭대학교 산학협력단 췌장암 환자의 항암제 치료 반응성 예측용 마커
JP2024501581A (ja) * 2020-12-08 2024-01-12 メモリアル スローン-ケタリング キャンサー センター ガレクチン-3に対する抗体及びその使用方法
CN112461915B (zh) * 2020-12-08 2024-07-12 杭州汇健科技有限公司 一种与药物敏感相关的特征分子筛选、药敏程度检测、细胞亚型检测的方法
WO2022140116A1 (en) 2020-12-21 2022-06-30 Freenome Holdings, Inc. Markers for the early detection of colon cell proliferative disorders
WO2022171777A1 (en) * 2021-02-12 2022-08-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for prognosis and treating a patient suffering from cancer
US12179064B2 (en) * 2021-04-11 2024-12-31 Vikas Khurana System, apparatus and method for training a subject
JP2024522607A (ja) * 2021-06-07 2024-06-21 フラッグシップ パイオニアリング イノベーションズ セブン,エルエルシー 治療薬の標的化送達のための組成物及び方法
CA3232274A1 (en) * 2021-09-20 2023-03-23 Jose P. Zevallos Drain fluid for diagnostics
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
US12416626B2 (en) 2022-07-22 2025-09-16 Droplet Biosciences, Inc. Methods for evaluating candidate therapy efficacy based on changes in lymphatic fluid biomarkers
WO2024086298A2 (en) * 2022-10-20 2024-04-25 The Johns Hopkins University Hla class i and class ii-restricted t-cell epitopes in pancreatic cancer tissues and uses thereof
WO2024206856A2 (en) * 2023-03-30 2024-10-03 Thomas Jefferson University Dna-dependent synthesis of rna by dna polymerase theta variants

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28937T1 (de) * 1982-08-09 1987-08-15 Centocor Inc Immunotest fuer kohlehydrat-antigen-determinant.
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体amc−462
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US6924153B1 (en) 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
JPH11225800A (ja) * 1998-02-10 1999-08-24 Kureha Chem Ind Co Ltd 体液を用いた癌検出方法及びキット
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
EP1298205A4 (en) * 2000-07-03 2004-06-16 Mochida Pharm Co Ltd NEW LIPASE
AU2002322864A1 (en) * 2001-08-03 2003-02-24 Origene Technologies, Inc. Full-length prostate selective polynucleotides and polypeptides
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
AU2003294828A1 (en) * 2002-12-17 2004-07-09 Sinogenomax Co. Ltd. Chinese National Human Genomecenter Specific markers for pancreatic cancer
JP4733644B2 (ja) * 2003-11-26 2011-07-27 ダナ−ファーバー キャンサー インスティテュート インク. 膵臓腺癌の動物モデルおよびその使用
DK1766412T3 (da) 2004-05-21 2009-05-25 Inst Systems Biology Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner
JP2009528507A (ja) 2006-03-02 2009-08-06 オンコセラピー・サイエンス株式会社 Reg4タンパク質を用いて膵癌を診断する方法
WO2009102788A2 (en) * 2008-02-15 2009-08-20 Mayo Foundation For Medical Education And Research Detecting neoplasm
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
CN102414565B (zh) * 2009-05-04 2014-09-24 霍夫曼-拉罗奇有限公司 作为癌症的标记物的DPPIV/Seprase的用途
WO2011027311A2 (en) * 2009-09-03 2011-03-10 Koninklijke Philips Electronics N.V. Novel tumor markers
CA2779730C (en) * 2009-11-05 2019-04-30 University Of Virginia Patent Foundation Compositions and methods for detecting plectin-1 as a biomarker for cancer
WO2011151252A2 (en) * 2010-06-01 2011-12-08 Metanomics Health Gmbh Means and methods for diagnosing pancreatic cancer in a subject
KR101857462B1 (ko) * 2010-08-13 2018-05-14 소마로직, 인크. 췌장암 바이오마커 및 그것의 용도
AU2011351990A1 (en) * 2010-12-29 2013-07-18 Expression Pathology, Inc. Protein biomarkers of recurrent breast cancer
EP2696202B1 (en) * 2011-04-05 2017-09-06 Olympus Corporation Pancreas test method, and pancreas test kit
HK1200037A1 (en) * 2011-09-12 2015-07-31 克里蒂科斯有限责任公司 Non-invasive methods of detecting target molecules

Similar Documents

Publication Publication Date Title
JP2016519285A5 (cg-RX-API-DMAC7.html)
EP3434787B1 (en) Phosphodiesterase 4d7 as prostate cancer marker
JP2025003539A (ja) c-MAFの状態に基づく乳がんの治療的処置
CN107076749B (zh) 转移性结直肠癌抗血管发生治疗相关预测和预后生物标志
ES2355388T3 (es) Métodos para la detección precoz de cáncer.
JP2013533977A5 (cg-RX-API-DMAC7.html)
JP2014524744A5 (cg-RX-API-DMAC7.html)
US8669067B2 (en) Cancer biomarker and the use thereof
CA2643611A1 (en) Biomarkers for head-and-neck cancers and precancers
US20120142012A1 (en) Biomarker for colorectal cancer
Dvořáková et al. Transgelin is upregulated in stromal cells of lymph node positive breast cancer
JP2020510409A5 (cg-RX-API-DMAC7.html)
Aktas et al. Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer
Andersen et al. Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome
WO2018223867A1 (zh) 一种前列腺癌的标志物spop及其在指导肿瘤治疗中的应用
CN103403550B (zh) 使用与braf v600e特异性结合的抗体诊断癌症的工具和方法
JP2016536568A5 (cg-RX-API-DMAC7.html)
WO2021116057A1 (en) Biomarker panel for diagnosing colorectal cancer
Lei et al. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma
Abdelgawad et al. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice
JP7271442B2 (ja) 腎機能を診断またはモニターする方法、または腎機能障害を診断することを補助する方法
EP3304086B1 (en) Method for predicting responsiveness to a combination therapy with lenvatinib and everolimus
ES2984122T3 (es) Biomarcadores para carcinoma de células renales
JP2012515893A5 (cg-RX-API-DMAC7.html)
JP2013533458A (ja) 前立腺癌におけるホルモンエスケープのマーカーとしてのcxcl5